Hospira Inc., A Pfizer Levophed norepinephrine bitartrate Recall

Why it was recalled

GMP Deviation; A foreign stopper was observed during packaging of a lot of product.

Product description

Levophed norepinephrine bitartrate, injection, USP, 4 mg /4 mL (1 mg/mL),Rx only, Hospira, Inc. Lake Forest, IL --- NDC 0409-3375-04

Lot numbers, UPCs & expiration codes

720503A, 720603A (Canada only)

Where it was sold

Nationwide, Canada and Singapore

What to do if you have this product

Compare the lot number and expiration date on your package with the codes above.
Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
If you have symptoms you think are related, contact your doctor. In an emergency call 911.
Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number: D-0898-2017
Classification: Class II
Status: Terminated
Recall initiated: May 18, 2017
FDA report date: Jun 21, 2017
Quantity: (720503A): 43,200 vials, (720603A): 400 vials
Recall type: Voluntary: Firm initiated
Recalling firm: Hospira Inc., A Pfizer Company

Original FDA data

Every field from FDA enforcement report D-0898-2017, exactly as published.

Show all FDA fields

City: Lake Forest
State: IL
Status: Terminated
Country: United States
Event ID: 77288
Address: 275 N Field Dr
Code information: 720503A, 720603A (Canada only)
Postal code: 60045-2579
Report date: Jun 21, 2017
Product type: Drugs
Recall number: D-0898-2017
Classification: Class II
Recalling firm: Hospira Inc., A Pfizer Company
Product quantity: (720503A): 43,200 vials, (720603A): 400 vials
Termination date: May 2, 2019
Reason for recall: GMP Deviation; A foreign stopper was observed during packaging of a lot of product.
Voluntary / mandated: Voluntary: Firm initiated
Product description: Levophed norepinephrine bitartrate, injection, USP, 4 mg /4 mL (1 mg/mL),Rx only, Hospira, Inc. Lake Forest, IL --- NDC 0409-3375-04
Distribution pattern: Nationwide, Canada and Singapore
Recall initiation date: May 18, 2017
Initial firm notification: Letter
Center classification date: Jun 9, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0898-2017, published Jun 21, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: Oct 2, 2026. Content last changed: Oct 2, 2026.

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.